Your browser doesn't support javascript.
loading
Efficacy and safety of anakinra in adults presenting deteriorating respiratory symptoms from COVID-19: A randomized controlled trial.
Audemard-Verger, Alexandra; Le Gouge, Amélie; Pestre, Vincent; Courjon, Johan; Langlois, Vincent; Vareil, Marc-Olivier; Devaux, Mathilde; Bienvenu, Boris; Leroy, Vincent; Goulabchand, Radjiv; Colombain, Léa; Bigot, Adrien; Guimard, Thomas; Douadi, Youcef; Urbanski, Geoffrey; Faucher, Jean François; Maulin, Laurence; Lioger, Bertrand; Talarmin, Jean-Philippe; Groh, Matthieu; Emmerich, Joseph; Deriaz, Sophie; Ferreira-Maldent, Nicole; Cook, Ann-Rose; Lengellé, Céline; Bourgoin, Hélène; Mekinian, Arsène; Aouba, Achille; Maillot, François; Caille, Agnès.
  • Audemard-Verger A; Department of Internal Medicine and Clinical Immunology, CHRU Tours, Tours, France.
  • Le Gouge A; University of Tours, Tours, France.
  • Pestre V; INSERM CIC1415, CHRU Tours, Tours, France.
  • Courjon J; Department of Internal Medicine and Infectious Diseases, CH Avignon, Avignon, France.
  • Langlois V; Department of Infectious Diseases, Université Côte d'Azur, CHU Nice, Nice, France.
  • Vareil MO; Department of Internal Medicine, CH du Havre, Le Havre, France.
  • Devaux M; Department of Infectious Diseases, CH de Bayonne, Bayonne, France.
  • Bienvenu B; Department of Internal Medicine, CH de Poissy, Poissy, France.
  • Leroy V; Department of Internal Medicine, Hôpital Saint Joseph, Marseille, France.
  • Goulabchand R; Department of Infectious Diseases, Clinique Tessier, Valenciennes, France.
  • Colombain L; Internal Medicine Department & Department of Infectious and Tropical Diseases, Nîmes University Hospital, University of Montpellier, Nîmes, France.
  • Bigot A; Department of Infectious Diseases, CH de Perpignan, Perpignan, France.
  • Guimard T; Department of Internal Medicine and Clinical Immunology, CHRU Tours, Tours, France.
  • Douadi Y; Department of Infectious Diseases, CH la Roche sur Yon, La Roche sur Yon, France.
  • Urbanski G; Department of Infectious Diseases, CH Saint Quentin, Saint Quentin, France.
  • Faucher JF; Department of Internal Medicine and Clinical Immunology, CHU Angers, Angers France.
  • Maulin L; Department of Infectious Diseases, CHU de Limoges, Limoges, France.
  • Lioger B; Department of Infectious Diseases, CH Aix en Provence, Aix en Provence, France.
  • Talarmin JP; Department of Internal Medicine, CH de Blois, Blois, France.
  • Groh M; Department of Internal Medicine and Infectious Diseases, CH de Quimper, Quimper, France.
  • Emmerich J; Department of Internal Medicine, Hôpital Foch, Suresnes, France.
  • Deriaz S; Department of Vascular Medicine, GH Saint Joseph and Université de Paris, INSERM CRESS 1153, Paris, France.
  • Ferreira-Maldent N; Department of Internal Medicine and Clinical Immunology, CHRU Tours, Tours, France.
  • Cook AR; Department of Internal Medicine and Clinical Immunology, CHRU Tours, Tours, France.
  • Lengellé C; Department of Internal Medicine and Clinical Immunology, CHRU Tours, Tours, France.
  • Bourgoin H; Clinical Research Vigilance Unit, CHRU Tours, Tours, France.
  • Mekinian A; Department of Pharmacology, CHRU Tours, Tours, France.
  • Aouba A; Department of Internal Medicine, Hôpital Saint Antoine, Sorbonne Université, Paris, France.
  • Maillot F; Department of Internal Medicine, CHU de Caen, Caen, France.
  • Caille A; Department of Internal Medicine and Clinical Immunology, CHRU Tours, Tours, France.
PLoS One ; 17(8): e0269065, 2022.
Article en En | MEDLINE | ID: mdl-35925914
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Tratamiento Farmacológico de COVID-19 Tipo de estudio: Clinical_trials / Diagnostic_studies / Guideline Límite: Adult / Humans Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Tratamiento Farmacológico de COVID-19 Tipo de estudio: Clinical_trials / Diagnostic_studies / Guideline Límite: Adult / Humans Idioma: En Año: 2022 Tipo del documento: Article